Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking

Nicotine and Tobacco Research

Volumn 13, Issue 9, 2011, Pages 833-839

  Marques Vidal, Pedro ^a   Kutalik, Zoltán ^b,c   Paccaud, Fred ^a   Bergmann, Sven ^b,c   Waeber, Gérard ^d   Vollenweider, Peter ^d   Cornuz, Jacques ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRNA3 GENE; FEMALE; GENE; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PRIORITY JOURNAL; PROMOTER REGION; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE;

EID: 80052714643     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr084     Document Type: Article

References (31)

1. Affymetrix. (2006). BRLMM: An improved genotype calling method for the GeneChip® Human Mapping 500K array set. (pp.) Author1-18. Retrieved from http://www.affymetrix.com/support/technical/whitepapers/brlmm_whitepaper.pdf.
2. Beuten, J., Ma, J. Z., Lou, X. Y., Payne, T. J., & Li, M. D. (2007). Association analysis of the protein phosphatase 1 regulatory subunit 1B (PPP1R1B) gene with nicotine dependence in European- and African-American smokers. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B, 285-290. doi:10.1002/ajmg.b.30399.
3. Beuten, J., Ma, J. Z., Payne, T. J., Dupont, R. T., Lou, X. Y., Crews, K. M., et al. (2007). Association of specific haplotypes of neurotrophic tyrosine kinase receptor 2 gene (NTRK2) with vulnerability to nicotine dependence in African-Americans and European-Americans. Biological Psychiatry, 61, 48-55. doi:10.1016/j.biopsych.2006.02.023.
4. Breitling, L. P., Dahmen, N., Mittelstrass, K., Illig, T., Rujescu, D., Raum, E., et al. (2009). Smoking cessation and variations in nicotinic acetylcholine receptor subunits alpha-5, alpha-3, and beta-4 genes. Biological Psychiatry, 65, 691-695. doi:10.1016/j.biopsych.2008.10.004.
5. Breitling, L. P., Dahmen, N., Mittelstrass, K., Rujescu, D., Gallinat, J., Fehr, C., et al. (2009). Association of nicotinic acetylcholine receptor subunit alpha 4 polymorphisms with nicotine dependence in 5500 Germans. Pharmacogenomics Journal, 9, 219-224. doi:10.1038/tpj.2009.6.
6. Caporaso, N., Gu, F., Chatterjee, N., Sheng-Chih, J., Yu, K., Yeager, M., et al. (2009). Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One, 4, e4653. doi:10.1371/journal.pone.0004653.
7. Chaiton, M. O., Cohen, J. E., McDonald, P. W., & Bondy, S. J. (2007). The Heaviness of Smoking Index as a predictor of smoking cessation in Canada. Addictive Behaviors, 32, 1031-1042. doi:10.1016/j.addbeh.2006.07.008.
8. Cinciripini, P., Wetter, D., Tomlinson, G., Tsoh, J., De, M. C., Cinciripini, L., et al. (2004). The effects of the DRD2 polymorphism on smoking cessation and negative affect: Evidence for a pharmacogenetic effect on mood. Nicotine & Tobacco Research, 6, 229-239. doi:10.1080/14622200410001676396.
9. Drgon, T., Montoya, I., Johnson, C., Liu, Q. R., Walther, D., Hamer, D., et al. (2009). Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Molecular Medicine (Cambridge, MA), 15, 21-27. doi:10.2119/molmed.2008.00096.
10. Firmann, M., Mayor, V., Marques-Vidal, P., Bochud, M., Pécoud, A., Hayoz, D., et al. (2008). The CoLaus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovascular Disorders, 8, 6. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2311269/?tool=pubmed.
11. Gauderman, W. J. (2002). Sample size requirements for association studies of gene-gene interaction. American Journal of Epidemiology, 155, 478-484. Retrieved from http://aje.oxfordjournals.org/content/155/5/478.long.
12. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., Rickert, W., & Robinson, J. (1989). Measuring the heaviness of smoking: Using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction, 84, 791-799. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2758152?dopt=Citation.
13. Hyland, A., Borland, R., Li, Q., Yong, H. H., McNeill, A., Fong, G. T., et al. (2006). Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tobacco Control, 15(Suppl. 3), iii83-iii94. doi:10.1136/tc.2005.013516.
14. Laucht, M., Becker, K., Frank, J., Schmidt, M. H., Esser, G., Treutlein, J., et al. (2008). Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 673-681. doi:10.1097/CHI.0b013e31816bff77.
15. Li, M. D. (2003). The genetics of smoking related behavior: A brief review. American Journal of Medical Sciences, 326, 168-173. Retrieved from http://ovidsp.tx.ovid.com/sp-3.2.4b/ovidweb.cgi?QS2=434f4e1a73d37e8c54b7bccef7797d0c596870292506a6673d7ba4481417968aaa2189a0a2935af1efdc5d52a079b262f7f7b2ab9727e5af7a8b3461d3bdbb662e3184b2cf2aa7ca7300b1738d50f21321136ede0c151f03845c0f7a6658ec110e5768744562f5d5593c53ef7bf2cc8a7ac41bc79419dab5ed7c2ef20162af5c81dcb9725cee21b918a01336d98677975bda77dd0079e3c37034fe9fe3946efb779edca1212c219aef093cf3b5e54ff477599d1df30665bf9d4383d9323402a103ae62db9296e1e552e4413520eb84001ff8e9a73d3de2c576d5c11ba688ecc84f88e8a150d8e0e6b4ee60100dcc42e09ebcf40a3deab0ab.
16. Li, M. D., Payne, T. J., Ma, J. Z., Lou, X. Y., Zhang, D., Dupont, R. T., et al. (2006). A genomewide search finds major susceptibility loci for nicotine dependence on chromosome 10 in African Americans. American Journal of Human Genetics, 79, 745-751. doi:10.1086/508208.
17. Li, M. D., Xu, Q., Lou, X. Y., Payne, T. J., Niu, T., & Ma, J. Z. (2009). Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 153B, 745-756. doi:10.1002/ajmg.b.31043.
18. Li, M. D., Yoon, D., Lee, J. Y., Han, B. G., Niu, T., Payne, T. J., et al. (2010). Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population. PLoS One, 5, e12183. doi:10.1371/journal.pone.0012183.
19. Liu, J. Z., Tozzi, F., Waterworth, D. M., Pillai, S. G., Muglia, P., Middleton, L., et al. (2010). Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics, 42, 436-440. doi:10.1038/ng.572.
20. Pillai, S. G., Ge, D., Zhu, G., Kong, X., Shianna, K. V., Need, A. C., et al. (2009). A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genetics, 5, e1000421. doi:10.1371/journal.pgen.1000421.
21. Pillai, S. G., Kong, X., Edwards, L. D., Cho, M., Anderson, W. H., Coxson, H. O., et al. (2010). Loci identified by genome-wide association studies influence different disease-related phenotypes in COPD. American Journal of Respiratory and Critical Care Medicine, 182, 1498-1505. doi:10.1164/rccm.201002-0151OC.
22. Prochaska, J. O., & DiClemente, C. C. (1992). Stages of change in the modification of problem behaviors. Progress in Behavior Modification, 28, 183-218. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1620663.
23. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., et al. (2007). PLINK: A tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics, 81, 559-575. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950838/?tool=pubmed.
24. Saccone, N. L., Culverhouse, R. C., Schwantes-An, T. H., Cannon, D. S., Chen, X., Cichon, S., et al. (2010). Multiple independent loci at chromosome 15q25.1 affect smoking quantity: A meta-analysis and comparison with lung cancer and COPD. PLoS Genetics, 6, pii. doi:10.1371/journal.pgen.1001053.
25. Section de Santé Office Fédéral de la Statistique. (2008). Enquête Suisse sur la Santé 2007. Les indices. [Swiss Health Survey 2007. Indexes]. Neuchâtel, Switzerland: Département Fédéral de l'Intérieur. Retrieved from http://www.bfs.admin.ch/bfs/portal/fr/index/infothek/erhebungen__quellen/blank/blank/ess/04.html.
26. Shiffman, S., Brockwell, S. E., Pillitteri, J. L., & Gitchell, J. G. (2008). Individual differences in adoption of treatment for smoking cessation: Demographic and smoking history characteristics. Drug and Alcohol Dependence, 93, 121-131. doi:10.1016/j.drugalcdep.2007.09.005.
27. Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., et al. (2008). A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452, 638-642. doi:10.1038/nature06846.
28. Thyrian, J. R., Panagiotakos, D. B., Polychronopoulos, E., West, R., Zatonski, W., & John, U. (2008). The relationship between smokers' motivation to quit and intensity of tobacco control at the population level: A comparison of five European countries. BMC Public Health, 8, 2. doi:10.1186/1471-2458-8-2.
29. Uhl, G. R., Liu, Q. R., Drgon, T., Johnson, C., Walther, D., Rose, J. E., et al. (2008). Molecular genetics of successful smoking cessation: Convergent genome-wide association study results. Archives of General Psychiatry, 65, 683-693. doi:10.1001/archpsyc.65.6.683.
30. Wewers, M. E., Stillman, F. A., Hartman, A. M., & Shopland, D. R. (2003). Distribution of daily smokers by stage of change: Current population survey results. Preventive Medicine, 36, 710-720. Retrieved from http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WPG-48B5KPX-5&_user=946202&_coverDate=06%2F30%2F2003&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000049005&_version=1&_urlVersion=0&_userid=946202&md5=5b9b13633db9d1ac6a84557129edb529&searchtype=a.
31. World Health Organization. (2008). WHO report on the global tobacco epidemic, 2008: The MPOWER package. Geneva, Switzerland. Retrieved from http://www.who.int/entity/tobacco/mpower/mpower_report_forward_summary_2008.pdf.